Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androfeme 5 mg versus 10 mg pharmacokinetic study in postmenopausal women
ACTRN12612001250820Phase 2Completed
- Sponsor
- Monash University
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of testosterone in Hypoandrogenism (TD), sponsored by Monash University. Primary endpoints: AUC(0-24), Cavg and 1 more. Started Apr 2014; status: completed.
02
Drugs
testosterone
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on ACTRN12612001250820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001250820.